Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 496 to 510 of 983 results for death

  1. Drug-eluting stents for treating coronary artery disease: late-stage assessment (HTG747)

    Late-stage assessment (LSA) guidance on drug-eluting stents for treating coronary artery disease.

    HealthTech guidance
    Published
    6 May 2025
    View recommendations

    Sections for HTG747

  2. What are the implications of FH for the safety of a mother during pregnancy and what are the risks of fetal malformations attributable to pharmacological therapies

    is also limited information on the risk of pregnancy (including cardiac death) in a woman with FH. Data on the incidence of cardiac...

    Research recommendation
    Published
    15 November 2019

  3. Artificial intelligence for analysing CT brain scans (MIB207)

    NICE has developed a medtech innovation briefing (MIB) on artificial intelligence for analysing CT brain scans .

    Medtech innovation briefing
    Published
    17 March 2020

  4. Signs and symptoms that predict neutropenic sepsis in the community:- A prospective study should be carried out to determine which signs and symptoms experienced by patients in the community predict neutropenic sepsis and the outcomes of these episodes.

    too narrow will delay the emergency treatment of infection and may lead to death, increased need for intensive or critical care...

    Research recommendation
    Published
    9 June 2015

  5. Perinatal palliative care:- What impact does timely perinatal palliative care have on the experience of bereaved parents?

    after birth.There is little evidence on the experience families have of the death of a baby with or without specific support from a...

    Research recommendation
    Published
    15 February 2017

  6. LATITUDE NXT Patient Management System for monitoring cardiac devices at home (MIB67)

    NICE has developed a medtech innovation briefing (MIB) on the LATITUDE NXT Patient Management System for monitoring cardiac devices at home

    Medtech innovation briefing
    Published
    24 May 2016

  7. Tezepelumab for treating severe asthma (TA880)

    Evidence-based recommendations on tezepelumab (Tezspire) for treating severe asthma in people 12 years and over.

    Technology appraisal guidance
    Published
    20 April 2023
    View recommendations

    Sections for TA880

  8. Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer (TA496)

    Evidence-based recommendations on ribociclib (Kisqali) as initial endocrine-based therapy for hormone-receptor positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic (secondary) breast cancer in adults.

    Technology appraisal guidance
    Published
    20 December 2017

    Sections for TA496

  9. Indoor air quality at home (NG149)

    This guideline covers indoor air quality in residential buildings. It aims to raise awareness of the importance of good air quality in people's homes and how to achieve this.

    NICE guideline
    Published
    8 January 2020
    View recommendations

    Sections for NG149

  10. Heart valve disease presenting in adults: investigation and management (NG208)

    This guideline covers investigation and management of heart valve disease presenting in adults. It aims to improve quality of life and survival for people with heart valve disease through timely diagnosis and appropriate intervention.

    NICE guideline
    Published
    17 November 2021
    View recommendations

    Sections for NG208

  11. Type 1 diabetes in adults: diagnosis and management (NG17)

    This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.

    NICE guideline
    Last updated
    17 August 2022
    View recommendations

    Sections for NG17

  12. Cemiplimab with platinum-based chemotherapy for untreated advanced non-small-cell lung cancer (TA1108)

    Evidence-based recommendations on cemiplimab (Libtayo) with platinum-based chemotherapy for untreated advanced non-small-cell lung cancer in adults.

    Technology appraisal guidance
    Published
    5 November 2025
    View recommendations

    Sections for TA1108

  13. Early revascularisation strategy for people with angina and multivessel disease:- In people with stable angina and multivessel disease (including left main stem disease) whose symptoms are controlled with optimal drug treatment, would an initial treatment strategy of revascularisation be clinically and cost effective compared with continued drug treatment?

    tests to identify whether they have a higher risk profile for early cardiac death, which could be reduced by revascularisation. This...

    Research recommendation
    Published
    9 June 2015

  14. Integrated patient information systems:- What is the clinical and cost effectiveness of different methods for integrating patient information throughout the emergency medical care pathway?

    multidisciplinary orcomplex care needs, and recognising a person's preferred place of death in palliative care. In many locations around...

    Research recommendation
    Published
    15 November 2018

  15. Prognostic tools:- Is the amyotrophic lateral sclerosis (ALS) Prognostic Index an accurate predictor of survival in people with MND under NHS care in England and/or Wales?

    being more aware of the likely progression and prepare themselves for the death of their loved one.Accurate predictions of survival...

    Research recommendation
    Published
    21 March 2016